ApolloMed reported a 40% increase in revenue to $317.0 million, but net income attributable to AMEH decreased to $26.0 million. The company closed acquisitions of All American Medical Group and Valley Oaks Medical Group in October 2022, and entered into an agreement to acquire For Your Benefit. The company is raising annual guidance for revenue, net income and EBITDA, and reiterating guidance for Adjusted EBITDA.
Revenue increased by 40% to $317.0 million compared to Q3 2021.
Net income attributable to AMEH was $26.0 million, compared to $34.3 million in the prior year.
Diluted EPS was $0.56, compared to $0.74 in the prior year.
Adjusted EBITDA was $57.1 million, compared to $62.9 million in the prior year.
The Company is raising annual guidance for revenue, net income and EBITDA, and reiterating guidance for Adjusted EBITDA.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance